CN111521775A - A method for preparing paper-based microfluidic chip for bisphenol A detection based on wax spray printing technology - Google Patents
A method for preparing paper-based microfluidic chip for bisphenol A detection based on wax spray printing technology Download PDFInfo
- Publication number
- CN111521775A CN111521775A CN202010288788.6A CN202010288788A CN111521775A CN 111521775 A CN111521775 A CN 111521775A CN 202010288788 A CN202010288788 A CN 202010288788A CN 111521775 A CN111521775 A CN 111521775A
- Authority
- CN
- China
- Prior art keywords
- paper
- bisphenol
- microfluidic chip
- based microfluidic
- printing technology
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- IISBACLAFKSPIT-UHFFFAOYSA-N bisphenol A Chemical compound C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 IISBACLAFKSPIT-UHFFFAOYSA-N 0.000 title claims abstract description 124
- 238000001514 detection method Methods 0.000 title claims abstract description 38
- 238000005516 engineering process Methods 0.000 title claims abstract description 34
- 238000000034 method Methods 0.000 title claims abstract description 30
- 238000007639 printing Methods 0.000 title claims abstract description 25
- 239000007921 spray Substances 0.000 title claims description 27
- 238000006243 chemical reaction Methods 0.000 claims abstract description 46
- 239000000758 substrate Substances 0.000 claims abstract description 26
- 239000000427 antigen Substances 0.000 claims abstract description 20
- 102000036639 antigens Human genes 0.000 claims abstract description 20
- 108091007433 antigens Proteins 0.000 claims abstract description 20
- 102000004190 Enzymes Human genes 0.000 claims abstract description 17
- 108090000790 Enzymes Proteins 0.000 claims abstract description 17
- 238000004458 analytical method Methods 0.000 claims abstract description 16
- 238000011161 development Methods 0.000 claims abstract description 13
- 238000012986 modification Methods 0.000 claims abstract description 13
- 230000004048 modification Effects 0.000 claims abstract description 13
- 230000002209 hydrophobic effect Effects 0.000 claims abstract description 11
- 230000008569 process Effects 0.000 claims abstract description 8
- 238000012545 processing Methods 0.000 claims abstract description 8
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 40
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 35
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 35
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 35
- 239000000243 solution Substances 0.000 claims description 19
- 230000000903 blocking effect Effects 0.000 claims description 17
- UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 claims description 14
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 8
- 239000000126 substance Substances 0.000 claims description 8
- PMUNIMVZCACZBB-UHFFFAOYSA-N 2-hydroxyethylazanium;chloride Chemical compound Cl.NCCO PMUNIMVZCACZBB-UHFFFAOYSA-N 0.000 claims description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 7
- 239000007853 buffer solution Substances 0.000 claims description 7
- 238000004587 chromatography analysis Methods 0.000 claims description 7
- 239000011248 coating agent Substances 0.000 claims description 7
- 238000000576 coating method Methods 0.000 claims description 7
- 229940073579 ethanolamine hydrochloride Drugs 0.000 claims description 7
- HZAXFHJVJLSVMW-UHFFFAOYSA-N monoethanolamine hydrochloride Natural products NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 claims description 7
- 150000002148 esters Chemical class 0.000 claims description 6
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 5
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 5
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 5
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 5
- 239000008367 deionised water Substances 0.000 claims description 5
- 229910021641 deionized water Inorganic materials 0.000 claims description 5
- 238000004108 freeze drying Methods 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 238000004737 colorimetric analysis Methods 0.000 claims description 4
- 239000012528 membrane Substances 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 3
- 229940040526 anhydrous sodium acetate Drugs 0.000 claims description 3
- 239000000872 buffer Substances 0.000 claims description 3
- 230000008105 immune reaction Effects 0.000 claims description 3
- 229910021642 ultra pure water Inorganic materials 0.000 claims description 3
- 239000012498 ultrapure water Substances 0.000 claims description 3
- AQLJVWUFPCUVLO-UHFFFAOYSA-N urea hydrogen peroxide Chemical compound OO.NC(N)=O AQLJVWUFPCUVLO-UHFFFAOYSA-N 0.000 claims description 3
- WHGYBXFWUBPSRW-FEYSZYNQSA-N β-dextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)C(O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FEYSZYNQSA-N 0.000 claims description 3
- 238000003491 array Methods 0.000 claims description 2
- 239000002981 blocking agent Substances 0.000 claims description 2
- 235000013336 milk Nutrition 0.000 claims description 2
- 239000008267 milk Substances 0.000 claims description 2
- 210000004080 milk Anatomy 0.000 claims description 2
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims 1
- 239000000835 fiber Substances 0.000 claims 1
- 238000007789 sealing Methods 0.000 claims 1
- AWLUSOLTCFEHNE-UHFFFAOYSA-N sodium;urea Chemical group [Na].NC(N)=O AWLUSOLTCFEHNE-UHFFFAOYSA-N 0.000 claims 1
- 238000005507 spraying Methods 0.000 abstract description 3
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 9
- 230000008901 benefit Effects 0.000 description 8
- 239000003153 chemical reaction reagent Substances 0.000 description 8
- 238000012360 testing method Methods 0.000 description 6
- 230000008878 coupling Effects 0.000 description 5
- 238000010168 coupling process Methods 0.000 description 5
- 238000005859 coupling reaction Methods 0.000 description 5
- 238000013461 design Methods 0.000 description 5
- 238000001179 sorption measurement Methods 0.000 description 5
- 230000004888 barrier function Effects 0.000 description 4
- 229920002678 cellulose Polymers 0.000 description 4
- 239000001913 cellulose Substances 0.000 description 4
- 230000000875 corresponding effect Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 238000002965 ELISA Methods 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical class OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000002596 correlated effect Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 230000002427 irreversible effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 238000012805 post-processing Methods 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000003908 quality control method Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 235000020183 skimmed milk Nutrition 0.000 description 2
- QACMXJJLQXUOPQ-UHFFFAOYSA-N 1,2-dichloroethane;3-(ethyliminomethylideneamino)-n,n-dimethylpropan-1-amine Chemical compound ClCCCl.CCN=C=NCCCN(C)C QACMXJJLQXUOPQ-UHFFFAOYSA-N 0.000 description 1
- UAIUNKRWKOVEES-UHFFFAOYSA-N 3,3',5,5'-tetramethylbenzidine Chemical compound CC1=C(N)C(C)=CC(C=2C=C(C)C(N)=C(C)C=2)=C1 UAIUNKRWKOVEES-UHFFFAOYSA-N 0.000 description 1
- ZYUVGYBAPZYKSA-UHFFFAOYSA-N 5-(3-hydroxybutan-2-yl)-4-methylbenzene-1,3-diol Chemical compound CC(O)C(C)C1=CC(O)=CC(O)=C1C ZYUVGYBAPZYKSA-UHFFFAOYSA-N 0.000 description 1
- 241001307241 Althaea Species 0.000 description 1
- 235000006576 Althaea officinalis Nutrition 0.000 description 1
- 229920003043 Cellulose fiber Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010043275 Teratogenicity Diseases 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 238000012742 biochemical analysis Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000009614 chemical analysis method Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- NHADDZMCASKINP-HTRCEHHLSA-N decarboxydihydrocitrinin Natural products C1=C(O)C(C)=C2[C@H](C)[C@@H](C)OCC2=C1O NHADDZMCASKINP-HTRCEHHLSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000000840 electrochemical analysis Methods 0.000 description 1
- 230000001779 embryotoxic effect Effects 0.000 description 1
- 231100000238 embryotoxicity Toxicity 0.000 description 1
- 239000000598 endocrine disruptor Substances 0.000 description 1
- 231100000049 endocrine disruptor Toxicity 0.000 description 1
- 210000000750 endocrine system Anatomy 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 239000003822 epoxy resin Substances 0.000 description 1
- 102000015694 estrogen receptors Human genes 0.000 description 1
- 108010038795 estrogen receptors Proteins 0.000 description 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
- LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 238000001459 lithography Methods 0.000 description 1
- 235000001035 marshmallow Nutrition 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 239000005022 packaging material Substances 0.000 description 1
- 238000004940 physical analysis method Methods 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 238000007781 pre-processing Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000004451 qualitative analysis Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 238000011897 real-time detection Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000002522 swelling effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 231100000211 teratogenicity Toxicity 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/581—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Dispersion Chemistry (AREA)
- Clinical Laboratory Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
Abstract
Description
技术领域:Technical field:
本发明涉及检测技术领域,尤其涉及一种基于喷蜡技术制备纸基微流控芯片用于双酚A的检测。The invention relates to the technical field of detection, in particular to a paper-based microfluidic chip prepared based on a wax spray technology for the detection of bisphenol A.
背景技术:Background technique:
微流控分析技术可以集成多个分析平台,极大程度地把整个分析平台的功能集成至小型的分析仪器中,甚至是集成微米级的微流控芯片上。微流控芯片作为微观尺度下的液体输运平台,可以对液体流动进行定量、稳定的控制,从而可以实现生化分析、DNA测续、蛋白质筛选、微液滴操控、细胞分离、材料合成等多种功能。微流控芯片技术具有消耗少、样品处理时间短、检测灵敏度高和分辨率高等优点,还可以把样品处理、分离、反应等与分析相关的过程集成在一起,大大的提高了分析的效率。相对于传统的实验室,微流控技术具有体积小型化、携带便携化、反应迅速化、样品需求少量化、多种功能集成化的优势。正因为这些优点,微流控技术是将现场快速、实时检测的概念转化为现实的理想平台,有着重大的研究价值和应用价。纸基芯品以其独特的优势在微流控芯片领域上大放光彩。Microfluidic analysis technology can integrate multiple analysis platforms, and to a great extent integrate the functions of the entire analysis platform into small analytical instruments, even on micron-scale microfluidic chips. As a liquid transport platform at the microscopic scale, the microfluidic chip can quantitatively and stably control the liquid flow, so as to realize biochemical analysis, DNA measurement, protein screening, microdroplet manipulation, cell separation, material synthesis, etc. a function. Microfluidic chip technology has the advantages of low consumption, short sample processing time, high detection sensitivity and high resolution. It can also integrate sample processing, separation, reaction and other analysis-related processes, which greatly improves the efficiency of analysis. Compared with traditional laboratories, microfluidic technology has the advantages of miniaturization, portability, rapid reaction, small sample requirements, and integration of various functions. Because of these advantages, microfluidic technology is an ideal platform to transform the concept of on-site rapid and real-time detection into reality, and has great research value and application value. Paper-based core products shine in the field of microfluidic chips with their unique advantages.
纸基微流控芯片(Paper-based Microfluidic Device)最初在2007年Whitesites研究小组提出的,以滤纸为基底材料,构建“纸上微型实验室”(Lab-on-paper),运用光刻、喷蜡打印、柔性印刷等技术制作而成,已经运用在生物分析、比色分析、电化学分析等研究领域。是以滤纸为基底,通过各种加工技术形成亲/疏水微细通道网络及相关分析器件,构建“纸上微型实验室”相比于传统的微流控芯片技术,纸基微流控芯片兼具纸的优点:成本低、工艺简单、后处理简单无污染、生物相容性强等。Paper-based Microfluidic Device was originally proposed by the Whitesites research group in 2007, using filter paper as the base material to build a "Lab-on-paper", using lithography, spraying It is made of wax printing, flexographic printing and other technologies, and has been used in biological analysis, colorimetric analysis, electrochemical analysis and other research fields. Based on filter paper, the hydrophilic/hydrophobic micro-channel network and related analysis devices are formed through various processing techniques, and a "paper-based micro-lab" is constructed. Compared with the traditional microfluidic chip technology, the paper-based microfluidic chip has both The advantages of paper: low cost, simple process, simple and pollution-free post-processing, strong biocompatibility, etc.
双酚A主要用于生产聚碳酸酯塑料和环氧树脂,是一种最常见的内分泌干扰物,可以经过多种途径释放,其对人体的健康造成了威胁。经动物实验表明双酚A具有环境激素的作用,即使低剂量的双酚A也能对动物产生不良的影响。 BPA还可通过食物链进入生物体并与雌激素受体相互作用,从而影响生殖、免疫、神经和内分泌系统。同时多项研究表明,双酚A具备一定的致畸性和胚胎毒性,能明显增加动物患癌症的概率。另外,双酚A还可与紫外线或镉发生协同作用,加重对人体的危害。随着BPA在塑料包装材料生产中的广泛应用,它往往被释放并转移到环境和食品中,因此,它的存在不容忽视。Bisphenol A is mainly used in the production of polycarbonate plastics and epoxy resins. It is one of the most common endocrine disruptors, which can be released through a variety of ways, posing a threat to human health. Animal experiments have shown that bisphenol A has the effect of environmental hormones, and even low doses of bisphenol A can have adverse effects on animals. BPA can also enter organisms through the food chain and interact with estrogen receptors, thereby affecting reproductive, immune, nervous and endocrine systems. At the same time, many studies have shown that bisphenol A has certain teratogenicity and embryotoxicity, which can significantly increase the probability of animals suffering from cancer. In addition, bisphenol A can also synergize with ultraviolet light or cadmium, increasing the harm to the human body. As BPA is widely used in the production of plastic packaging materials, it is often released and transferred to the environment and food, so its presence cannot be ignored.
目前为止,双酚A的检测主要依靠高效液相色谱法(HPLC)、气相色谱.质谱(GC-MS)法、液相色谱-多级质谱联用等理化分析手段,基于色谱或色质联用的检测方法一般都具有灵敏度高、选择性好、精密度高的特性,但其需要在实验室完成,需要受过培训的专业人员,所使用仪器大多很昂重,操作复杂,耗时较长,难以满足大量样品高通量、快速检测的需要。因此,研究特异性灵敏、方便高效的双酚A快速检测方法,发展相应的检测技术及设备具有重要的科学和现实意义。So far, the detection of bisphenol A mainly relies on physical and chemical analysis methods such as high performance liquid chromatography (HPLC), gas chromatography-mass spectrometry (GC-MS), liquid chromatography-multi-stage mass spectrometry, etc. The detection methods used generally have the characteristics of high sensitivity, good selectivity and high precision, but they need to be completed in the laboratory and require trained professionals. Most of the instruments used are expensive, complicated to operate, and time-consuming. , it is difficult to meet the needs of high-throughput and rapid detection of a large number of samples. Therefore, it is of great scientific and practical significance to study a specific, sensitive, convenient and efficient rapid detection method for bisphenol A, and to develop the corresponding detection technology and equipment.
发明内容SUMMARY OF THE INVENTION
本发明公开了一种基于喷蜡技术制备纸基微流控芯片用于快速检测双酚A 的方法。利用喷蜡打印技术可实现灵活设计图案,结合易加工、易操作、便携化的纸基微流控技术和双酚A抗体与羧甲基纤维素钠吸附的稳定结合,并获得双酚A标准曲线建立了一种快速准确、高灵敏的双酚A检测方法。The invention discloses a method for rapidly detecting bisphenol A by preparing a paper-based microfluidic chip based on a wax spray technology. The use of wax spray printing technology can realize flexible design patterns, combined with paper-based microfluidics technology that is easy to process, easy to operate, and portable, and the stable combination of bisphenol A antibody and sodium carboxymethyl cellulose adsorption, and obtain bisphenol A standard The curve established a fast, accurate and highly sensitive method for the detection of BPA.
本发明的目的是这样实现的。一种基于喷蜡打印技术制备纸基微流控芯片用于双酚A检测的方法,包括如下步骤:The object of the present invention is achieved in this way. A method for preparing a paper-based microfluidic chip for bisphenol A detection based on a wax spray printing technology, comprising the following steps:
(1)以色谱纸为基底,通过CAD绘制好的模板经喷蜡打印机打印使,所述模板包括疏水通道和亲水通道,所述亲水通道包括用于发生免疫反应的反应区,该反应区为封闭型反应区;将打印好图案的色谱纸置于烘箱烘烤得到纸基微流控芯片;(1) Using chromatographic paper as the base, the template drawn by CAD is printed by a wax spray printer. The template includes a hydrophobic channel and a hydrophilic channel, and the hydrophilic channel includes a reaction area for immune reaction. The zone is a closed reaction zone; the chromatographic paper with the printed pattern is placed in an oven to bake to obtain a paper-based microfluidic chip;
(2)反应区进行改性处理:所述反应区内纸基微流控芯片经过表面改性处理;(2) Modification treatment in the reaction zone: the paper-based microfluidic chip in the reaction zone is subjected to surface modification treatment;
(3)在反应区加入待测抗原对应的包被抗体;(3) adding the coating antibody corresponding to the antigen to be tested in the reaction zone;
(4)在反应区内加入封闭剂;(4) adding blocking agent in the reaction zone;
(5)通过比色法实现对双酚A的检测。(5) The detection of bisphenol A is realized by colorimetric method.
优选的,将打印好图案的色谱纸置于110℃烘箱中烘烤5-8min。Preferably, the chromatographic paper with the printed pattern is placed in an oven at 110° C. for 5-8 minutes.
优选的,步骤(1)得到的纸基微流控芯片采用12×6阵列,反应区为直径为 5mm的小孔,孔间距为8mm,为了抑制样品在纸间流动,使用AutoCAD在白色背景上设计疏水屏障为黑色,采用12×6阵列的好处在于:前三排12×3列可以一次做出标准曲线,减少重复操作造成的人为误差,后三排12×3列可以用于多个样品的检测,保证样品和标准曲线在同一条件下进行操作,可提高检测的准确性。本发明设计12×6的微流控芯片方列,该优点是可以一次检测多个样品,节省时间的同时对样品进行重复检测,以提高检测的准确度;Preferably, the paper-based microfluidic chip obtained in step (1) adopts a 12×6 array, the reaction area is a small hole with a diameter of 5mm, and the hole spacing is 8mm. In order to suppress the flow of the sample between the papers, use AutoCAD on a white background The hydrophobic barrier is designed to be black, and the advantages of using a 12×6 array are: the first three rows of 12×3 columns can make a standard curve at one time, reducing the human error caused by repeated operations, and the last three rows of 12×3 columns can be used for multiple samples It can improve the detection accuracy by ensuring that the samples and the standard curve are operated under the same conditions. The invention designs a 12×6 square array of microfluidic chips, which has the advantage of being able to detect multiple samples at one time, saving time and repeating the detection of the samples to improve the detection accuracy;
优选的,步骤(1)所用色谱纸是whatman色谱纸。whatman色谱纸的质量和均一性较好。Preferably, the chromatography paper used in step (1) is whatman chromatography paper. The quality and uniformity of whatman chromatography paper is good.
优选的,步骤(2)纸基微流控芯片使用羧甲基纤维素钠进行表面改性处理,使所述纸基微流控芯片表面上带有羧基,具体步骤如下:将羧甲基纤维素钠溶解在去离子水中,用10-12kDa滤膜将其透析至无盐状态,再经冷冻干燥5-10min,经冷冻干燥后得到的羧甲基纤维素钠类似棉花糖状态。将纯化后的羧甲基纤维素溶于氯化钙溶液中,取0.2g/L羧甲基纤维素钠10-15μL滴在制作好的纸基微流控孔中。通过对纸基微流控芯片表面进行改性,使纸基微流控芯片表面带有羧基,可以提高抗体的偶联率,为后续样品和酶标抗原的加入提供了更多的结合位点。Preferably, in step (2), the paper-based microfluidic chip is surface-modified with sodium carboxymethyl cellulose, so that the surface of the paper-based microfluidic chip has carboxyl groups. The specific steps are as follows: The sodium carboxymethyl cellulose is dissolved in deionized water, dialyzed to a salt-free state with a 10-12kDa filter membrane, and then freeze-dried for 5-10 minutes. The sodium carboxymethyl cellulose obtained after freeze-drying is similar to marshmallows. Dissolve the purified carboxymethyl cellulose in calcium chloride solution, and drop 10-15 μL of 0.2 g/L sodium carboxymethyl cellulose into the prepared paper-based microfluidic well. By modifying the surface of the paper-based microfluidic chip, the surface of the paper-based microfluidic chip has carboxyl groups, which can improve the coupling rate of antibodies and provide more binding sites for subsequent samples and enzyme-labeled antigens. .
纸基改性通常用壳聚糖戊二醛,而本发明用羧甲基纤维素钠对纸基纤维素进行表面功能化,选择羧甲基纤维素钠是因为其化学和物理特性。也就是说,它具有羧基(适用于EDC/NHS化学),并且在合适的条件下不可逆地吸附在纸基纤维素纤维上。不可逆吸附不仅是因为电荷排斥力降低,还因为羧甲基纤维素钠未取代的吡喃葡萄糖苷与纤维素的吡喃葡萄糖苷之间的氢键键合所致。除电荷外,羧甲基纤维素钠的添加还改变了纸基纤维素的其他物理性能,例如表面溶胀,还能发生水合作用。增强的溶胀特性和类似水凝胶的结构能促进生物分子的固定和稳定性,从而有利于亲水性环境。通过不可逆的羧甲基纤维素钠的吸附作用,然后将抗体与羧甲基纤维素钠共价连接。这将为后续免疫测定提供稳定的纤维素生物界面。实现了双酚A抗体与羧甲基纤维素钠吸附的稳定结合,并获得双酚A 标准曲线。同时用羧甲基纤维素钠对纸基表面改性还可防止非特异性蛋白吸附。The paper-based modification usually uses chitosan glutaraldehyde, while the present invention uses sodium carboxymethyl cellulose to surface functionalize the paper-based cellulose, which is selected because of its chemical and physical properties. That is, it has carboxyl groups (for EDC/NHS chemistry) and is irreversibly adsorbed on paper-based cellulose fibers under suitable conditions. The irreversible adsorption is not only due to the reduced charge repulsion but also due to the hydrogen bonding between the unsubstituted glucopyranoside of sodium carboxymethylcellulose and the glucopyranoside of cellulose. In addition to the charge, the addition of sodium carboxymethyl cellulose also changed other physical properties of the paper-based cellulose, such as surface swelling and hydration. The enhanced swelling properties and hydrogel-like structure can facilitate immobilization and stability of biomolecules, thereby favoring a hydrophilic environment. Antibodies are then covalently linked to sodium carboxymethylcellulose by irreversible adsorption of sodium carboxymethylcellulose. This will provide a stable cellulose biointerface for subsequent immunoassays. The stable binding of bisphenol A antibody to the adsorption of sodium carboxymethyl cellulose was achieved, and the standard curve of bisphenol A was obtained. At the same time, the surface modification of paper base with sodium carboxymethyl cellulose can also prevent non-specific protein adsorption.
优选的,步骤(3)在反应区加入待测抗原对应的包被抗体,包被抗体与纸基微流控芯片表面上的羧基交联固定具体步骤为:在改性好的纸基微流控芯片表面上用3-6μL4mg/mL EDC1-(3-二甲氨基丙基)-3-乙基碳二亚胺)、3-6μL6 mg/mL NHS(N-N-羟基琥珀酰亚胺)活化12-18min,将羧甲基纤维素钠的羧基转化为胺反应酯,然后在pH7.5的PBS缓冲溶液中,将双酚A单克隆抗体按一定量共价结合在羧甲基纤维素钠改性的活化位点上;用pH8.5的盐酸乙醇胺溶液除去未反应的NHS,再用PBST除去未连接的双酚A抗体。Preferably, in step (3), a coating antibody corresponding to the antigen to be tested is added to the reaction area, and the coating antibody is cross-linked with the carboxyl groups on the surface of the paper-based microfluidic chip. The specific steps are: in the modified paper-based microfluidic chip The surface of the control chip was activated with 3-6 μL of 4 mg/mL EDC1-(3-dimethylaminopropyl)-3-ethylcarbodiimide), 3-6 μL of 6 mg/mL NHS (N-N-hydroxysuccinimide)12 -18min, convert the carboxyl group of sodium carboxymethyl cellulose into amine-reactive ester, and then in PBS buffer solution with pH 7.5, covalently bind bisphenol A monoclonal antibody to sodium carboxymethyl cellulose in a certain amount. On the active site of the activity; use pH 8.5 ethanolamine hydrochloride solution to remove unreacted NHS, and then use PBST to remove unconnected bisphenol A antibody.
优选的,步骤(4)封闭过程是:取1mg/ml的乳粉封闭液8-12μL滴在纸基微流控孔中进行封闭,之后用PBST洗涤三次,洗涤过量的封闭液。Preferably, the blocking process in step (4) is as follows: 8-12 μL of 1 mg/ml milk powder blocking solution is dropped into the paper-based microfluidic well for blocking, and then washed three times with PBST to wash the excess blocking solution.
优选的,步骤(5)检测包括如下步骤:Preferably, the step (5) detection includes the following steps:
(1)将不同浓度的双酚A标品和酶标抗原以1:1的体积比加入5μL到微流控反应孔中进行反应,之后用10μLPBSTbuffer洗涤四次;(1) Add 5 μL of different concentrations of bisphenol A standard and enzyme-labeled antigen into the microfluidic reaction well at a volume ratio of 1:1, and then wash with 10 μL PBSTbuffer four times;
(2)显色:底物A和底物B混合,取5μL混合液加到微流控反应孔中进行显色,显色后用手机拍照;(2) Color development: Mix substrate A and substrate B, add 5 μL of the mixture to the microfluidic reaction well for color development, and take pictures with a mobile phone after color development;
(3)分析:用Excel和ImageJ软件进行数据处理和灰度分析,绘制标准曲线。(3) Analysis: Data processing and grayscale analysis were performed with Excel and ImageJ software, and a standard curve was drawn.
优选的,底物A与底物B的体积比为32.44:1;底物A是0.43g过氧化氢脲、2.5gβ糊精和8.2g无水乙酸钠调pH至5.0,用超纯水定容至1000ml,4℃保存,使用前从4℃取出恢复至室温;底物B是100mgTMB(3,3',5,5'-四甲基联苯胺)和10ml DMSO(二甲基亚砜)混合,于棕色瓶中阴凉处储存备用。Preferably, the volume ratio of Substrate A to Substrate B is 32.44:1; Substrate A is 0.43g urea hydrogen peroxide, 2.5g β-dextrin and 8.2g anhydrous sodium acetate to adjust the pH to 5.0, and determine with ultrapure water. Make up to 1000ml, store at 4°C, take out from 4°C and return to room temperature before use; Substrate B is 100mg TMB (3,3',5,5'-tetramethylbenzidine) and 10ml DMSO (dimethyl sulfoxide) Mix and store in a brown bottle in a cool place until later.
本技术方案的原理是:结合在纸基表面的抗体仍保持其免疫学活性,酶标记的抗原既保留其免疫学活性,又保留酶的活性。检测时,样品中的受检物质(抗原)和酶标抗原与固定的抗体竞争性结合,通过洗涤除去非结合物,能固定下来的酶量与样品中被检物质的量相关。通过加入与酶反应的底物后显色,根据颜色的深浅可以判断样品中物质的含量,进行定性或定量的分析。由于酶的催化效率很高,间接地放大了免疫反应的结果,使测定方法达到很高的灵敏度。The principle of the technical solution is that the antibody bound to the surface of the paper base still maintains its immunological activity, and the enzyme-labeled antigen retains both its immunological activity and the enzymatic activity. During detection, the test substance (antigen) and the enzyme-labeled antigen in the sample competitively bind with the immobilized antibody, and the unbound substances are removed by washing, and the amount of the enzyme that can be immobilized is related to the amount of the test substance in the sample. By adding the substrate reacting with the enzyme, the color is developed, and the content of the substance in the sample can be judged according to the depth of the color, and the qualitative or quantitative analysis can be carried out. Due to the high catalytic efficiency of the enzyme, the results of the immune reaction are indirectly amplified, and the assay method achieves high sensitivity.
本发明设计的纸基微流控芯品,是以色谱纸为基底,通过喷蜡加工技术形成亲/疏水微细通道网络及相关分析器件,构建“纸上微型实验室”相比于传统的微流控芯片技术,纸基微流控芯片兼具纸的优点:成本低、工艺简单、后处理简单无污染、生物相容性强等特点。The paper-based microfluidic core product designed in the present invention takes chromatographic paper as the base, forms hydrophilic/hydrophobic micro-channel network and related analysis devices through wax spray processing technology, and builds a "miniature laboratory on paper". Fluidic chip technology, paper-based microfluidic chip has the advantages of paper: low cost, simple process, simple and pollution-free post-processing, and strong biocompatibility.
大型仪器检测需要先进且昂贵的仪器,以及复杂、费力且耗时的预处理步骤。传统的酶联免疫法(ELISA)相对昂贵,因为它需要大量的分析物样品和试剂(尤其是抗体)以及昂贵的酶标仪来收集数据。然而,采用本方法检测双酚A,不仅可以节约分析试剂用量(仅需要几μL试剂量)、节省样品预处理时间以及大大降低检测时间,同时降低了检测成本,可以满足快速、灵敏和准确的现场检测或日常测试的需求。Large-scale instrumentation requires advanced and expensive instrumentation, as well as complex, laborious, and time-consuming preprocessing steps. Traditional enzyme-linked immunosorbent assay (ELISA) is relatively expensive because it requires large amounts of analyte samples and reagents (especially antibodies) and an expensive microplate reader to collect data. However, using this method to detect bisphenol A can not only save the amount of analytical reagents (only a few μL of reagents are needed), save the sample pretreatment time and greatly reduce the detection time, but also reduce the detection cost, and can meet the requirements of rapid, sensitive and accurate detection. On-site testing or routine testing needs.
附图说明:Description of drawings:
图1为本发明一种基于喷蜡打印技术制备纸基微流控芯片用于检测双酚A所用工作试剂体积;Fig. 1 is a kind of working reagent volume used in the preparation of paper-based microfluidic chip based on wax spray printing technology for detecting bisphenol A of the present invention;
图2为本发明一种基于喷蜡打印技术制备纸基微流控芯片用于检测双酚A的微流控芯片模板;2 is a microfluidic chip template for preparing a paper-based microfluidic chip for detecting bisphenol A based on the wax spray printing technology of the present invention;
图3为本发明一种基于喷蜡打印技术制备纸基微流控芯片用于检测双酚A的工作原理;3 is a working principle of a paper-based microfluidic chip prepared based on the wax spray printing technology for detecting bisphenol A according to the present invention;
图4为本发明一种基于喷蜡打印技术制备纸基微流控芯片用于检测双酚A的标准曲线;FIG. 4 is a standard curve of a paper-based microfluidic chip prepared based on the wax spray printing technology of the present invention for detecting bisphenol A;
图5为本发明一种基于喷蜡打印技术制备纸基微流控芯片用于检测双酚A的实验过程中抗体包被量优化。FIG. 5 shows the optimization of the amount of antibody coating in the experimental process of preparing a paper-based microfluidic chip based on the wax spray printing technology for the detection of bisphenol A according to the present invention.
具体实施方式:Detailed ways:
下面结合附图进一步说明The following is a further description in conjunction with the accompanying drawings
本发明的工作原理是:利用喷蜡打印机在色谱纸上制备纸基芯片,双酚A 单克隆抗体固定于改性过的纸基上,根据抗原抗体、酶专一性催化底物显色的原理,将双酚A标品和酶标抗原加入到芯片中,标品和酶标抗原竞争性与抗体结合,随着标品浓度的增加,酶标抗原与纸基上的抗体结合逐渐减少,颜色逐渐变浅,通过Image J分析颜色的灰度值,如图4可以看出,随着浓度的对数增加,相对灰度值逐渐增高,故可通过比色法检测双酚A。The working principle of the invention is as follows: a paper-based chip is prepared on a chromatographic paper by using a wax spray printer, the bisphenol A monoclonal antibody is fixed on the modified paper base, and the color-developing substrate is catalyzed according to the specificity of the antigen, antibody and enzyme. In principle, the bisphenol A standard and enzyme-labeled antigen are added to the chip, and the standard and enzyme-labeled antigen competitively bind to the antibody. The color gradually becomes lighter, and the gray value of the color is analyzed by Image J. As can be seen in Figure 4, as the logarithm of the concentration increases, the relative gray value gradually increases, so BPA can be detected by colorimetry.
实施例1Example 1
研究微流控芯片所需工作试剂的步骤如下:The steps to study the working reagents required for the microfluidic chip are as follows:
(1)用CAD绘图:采用12×6阵列,反应区直径为5mm,孔间距为8mm,为了抑制样品在纸间流动,使用Auto CAD在白色背景上设计疏水通道为黑色。(1) Drawing with CAD: A 12×6 array was used, the diameter of the reaction zone was 5mm, and the hole spacing was 8mm. In order to suppress the flow of the sample between the papers, Auto CAD was used to design the hydrophobic channel to be black on a white background.
(2)蜡打印机打印:使用蜡打印机在色谱纸上印刷微流控纸基图案。(2) Wax printer printing: Microfluidic paper-based patterns were printed on chromatographic paper using a wax printer.
(3)将打印好图案的色谱纸置于110℃烘箱中烘烤6min,将蜡融化。(3) Place the printed chromatographic paper in a 110°C oven for 6 minutes to melt the wax.
为了确定纸基芯片上所需的工作试剂(PBST buffer、封闭液、样品、底物 A+底物B)体积,将不同体积(1-10μL)的结晶紫染料溶液[0.025%(w/v)] 加入到芯片中,然后在室温下用肉眼评估结果。由图1能看出所能承受的最大试剂量,和刚好不渗透的试剂量为10μL。To determine the required volume of working reagents (PBST buffer, blocking solution, sample, substrate A + substrate B) on the paper-based chip, different volumes (1-10 μL) of crystal violet dye solution [0.025% (w/v) ] were added to the chip and the results were evaluated visually at room temperature. It can be seen from Figure 1 that the maximum amount of reagent that can be tolerated, and the amount of reagent that is just impermeable is 10 μL.
最后选择所述的微流控芯片所需的PBST buffer为10μL,样品和酶标抗原以 1:1体积比混合为5μL,封闭液为10μL,底物(底物A与底物B的体积比为32.44: 1)为5μL,底物A是0.43g过氧化氢脲、2.5gβ糊精和8.2g无水乙酸钠调pH 至5.0,用超纯水定容至1000ml,4℃保存备用,使用前从4℃取出恢复至室温;底物B是100mg TMB和10mL DMSO混合,于棕色瓶中阴凉处储存备用。Finally, the PBST buffer required for the microfluidic chip was selected as 10 μL, the sample and enzyme-labeled antigen were mixed at a volume ratio of 1:1 to 5 μL, the blocking solution was 10 μL, and the volume ratio of substrate (substrate A to substrate B) was selected. 32.44: 1) 5μL, the substrate A is 0.43g urea hydrogen peroxide, 2.5g β-dextrin and 8.2g anhydrous sodium acetate, adjust the pH to 5.0, make up to 1000ml with ultrapure water, store at 4°C for later use Take it out from 4°C and return to room temperature before; Substrate B is a mixture of 100 mg TMB and 10 mL DMSO, and is stored in a brown bottle in a cool place for later use.
实施例2Example 2
本发明所述的一种基于喷蜡技术制备纸基微流控芯片用于检测双酚A的步骤如下:The steps of preparing a paper-based microfluidic chip for detecting bisphenol A based on the wax spray technology of the present invention are as follows:
(1)用CAD绘图:采用12×6阵列,反应区直径为5mm,孔间距为8mm,为了抑制样品在纸间流动,使用Auto CAD在白色背景上设计的疏水屏障为黑色。(1) Drawing with CAD: A 12×6 array was used, the diameter of the reaction zone was 5 mm, and the hole spacing was 8 mm. In order to inhibit the flow of the sample between the papers, the hydrophobic barrier designed on a white background using Auto CAD was black.
(2)蜡打印机打印:使用蜡打印机在whatman色谱纸上印刷微流控图案。(2) Wax printer printing: Microfluidic patterns were printed on whatman chromatography paper using a wax printer.
(3)将打印好图案的色谱纸置于110℃烘箱中烘烤6min,将蜡融化。(3) Place the printed chromatographic paper in a 110°C oven for 6 minutes to melt the wax.
(4)纸基反应区表面改性:用羧甲基纤维素钠进行表面改性,具体步骤如下:将羧甲基纤维素钠溶解在去离子水中,用11kDa滤膜将其透析至无盐状态,在经冷冻干燥8min,将纯化后的羧甲基纤维素溶于氯化钙溶液中,取0.2g/L羧甲基纤维素钠13μL滴在制作好的纸基微流控孔中。(4) Surface modification of the paper-based reaction zone: surface modification with sodium carboxymethyl cellulose, the specific steps are as follows: dissolving sodium carboxymethyl cellulose in deionized water, and dialyzing it to salt-free with a 11kDa filter membrane After freeze-drying for 8 min, the purified carboxymethyl cellulose was dissolved in calcium chloride solution, and 13 μL of 0.2 g/L sodium carboxymethyl cellulose was dropped into the prepared paper-based microfluidic well.
(5)抗体固定于反应区中:在改性好的纸基微流控芯片表面上用5μL EDC(4 mg/ml)、5μL NHS(6mg/ml)活化15min,将羧甲基纤维素钠羧基转化为胺反应酯,然后在pH7.5的PBS缓冲溶液中,将双酚A单克隆抗体按照0.1μg/well 的量共价结合在羧甲基纤维素钠改性的活化位点上;用pH8.5的盐酸乙醇胺溶液除去未反应的NHS,再用PBST除去未连接的双酚A抗体。(5) The antibody was immobilized in the reaction zone: activated on the surface of the modified paper-based microfluidic chip with 5 μL EDC (4 mg/ml) and 5 μL NHS (6 mg/ml) for 15 min, and sodium carboxymethyl cellulose was The carboxyl group was converted into an amine-reactive ester, and then the bisphenol A monoclonal antibody was covalently bound to the activated site modified by sodium carboxymethyl cellulose according to the amount of 0.1 μg/well in PBS buffer solution with pH 7.5; Unreacted NHS was removed with ethanolamine hydrochloride solution at pH 8.5, and unlinked bisphenol A antibody was removed with PBST.
(6)封闭:取1mg/mL的脱脂乳粉封闭液10μL,滴在纸基微流控孔中进行封闭,之后用PBST洗涤三次,洗涤过量的封闭液。(6) Blocking: Take 10 μL of 1 mg/mL skimmed milk powder blocking solution, drop it into a paper-based microfluidic well for blocking, and then wash with PBST three times to wash the excess blocking solution.
实施例3Example 3
按照实施例2的方法,只是步骤(5)加入双酚A单克隆抗体的量不同,A-F分别表示偶联抗体量为0.4、0.2、0.1、0.05、0.025、0.0125μg/well,并进行下一步反应并做三组对比,其中1.4.7列为对照组(反应中加的样品为2.5μL PBS+2.5μL 酶标抗原);2.5.8列为实验组(反应中加样2.5μL 1ppm的双酚A标品+2.5μl 酶标抗原);3.6.9列为空白(反应中加样为5μL PBS)。由图5可以看出对照组显色最深,实验组显色稍浅,空白组颜色最浅。通过实验发现,随着抗体偶联量的逐渐减少,显色程度逐渐降低,颜色差异不明显,会影响实验的精确度;当偶联量为0.1μg/well时,背景颜色干扰最低,实验组颜色显色适中,颜色与样品浓度成负相关线性趋势显著;当抗体偶联量超过0.1μg/well时,会造成抗体不必要的浪费,故抗体偶联量0.1μg/well时效果较好。According to the method of Example 2, except that the amount of bisphenol A monoclonal antibody added in step (5) is different, A-F indicates that the amount of conjugated antibody is 0.4, 0.2, 0.1, 0.05, 0.025, 0.0125 μg/well, respectively, and proceed to the next step Reactions and three groups were compared, of which 1.4.7 was listed as the control group (the sample added in the reaction was 2.5μL PBS+2.5μL enzyme-labeled antigen); Phenol A standard substance + 2.5 μl enzyme-labeled antigen); 3.6.9 is listed as blank (5 μL PBS was added in the reaction). It can be seen from Figure 5 that the color of the control group is the darkest, the color of the experimental group is slightly lighter, and the color of the blank group is the lightest. Through experiments, it was found that with the gradual reduction of the antibody coupling amount, the degree of color development gradually decreased, and the color difference was not obvious, which would affect the accuracy of the experiment; when the coupling amount was 0.1 μg/well, the background color interference was the lowest, and the experimental group The color development is moderate, and the color is negatively correlated with the sample concentration, and the linear trend is significant; when the antibody coupling amount exceeds 0.1 μg/well, it will cause unnecessary waste of antibody, so the effect is better when the antibody coupling amount is 0.1 μg/well.
实施例4Example 4
本发明所述的一种基于喷蜡技术制备纸基微流控芯片用于检测双酚A的步骤如下:The steps of preparing a paper-based microfluidic chip for detecting bisphenol A based on the wax spray technology of the present invention are as follows:
(1)用CAD绘图:采用12×6阵列,反应区直径为5mm,孔间距为8mm,为了抑制样品在纸间流动,使用AutoCAD在白色背景上设计疏水屏障为黑色。(1) Drawing with CAD: 12 × 6 arrays were used, the diameter of the reaction area was 5 mm, and the hole spacing was 8 mm. In order to suppress the flow of the sample between the papers, AutoCAD was used to design the hydrophobic barrier to be black on a white background.
(2)蜡打印机打印:使用蜡打印机在whatman色谱纸上印刷微流控图案。(2) Wax printer printing: Microfluidic patterns were printed on whatman chromatography paper using a wax printer.
(3)将打印好图案的色谱纸置于110℃烘箱中烘烤5min,将蜡融化。(3) Place the printed chromatographic paper in a 110°C oven for 5 minutes to melt the wax.
(4)纸基反应区表面改性:用羧甲基纤维素钠进行表面改性,具体步骤如下:将羧甲基纤维素钠溶解在去离子水中,用10kDa滤膜将其透析至无盐状态,在经冷冻干燥5min,将纯化后的羧甲基纤维素溶于氯化钙溶液中,取0.2g/L羧甲基纤维素钠10μL滴在制作好的纸基微流控孔中。(4) Surface modification of paper-based reaction zone: surface modification with sodium carboxymethyl cellulose, the specific steps are as follows: dissolving sodium carboxymethyl cellulose in deionized water, and dialyzing it to salt-free with a 10kDa filter membrane After freeze-drying for 5 min, the purified carboxymethyl cellulose was dissolved in calcium chloride solution, and 10 μL of 0.2 g/L sodium carboxymethyl cellulose was dropped into the prepared paper-based microfluidic well.
(5)抗体固定于反应区中:在改性好的纸基微流控芯片表面上用3μL EDC(4 mg/ml)、3μL NHS(6mg/ml)活化10min,将羧甲基纤维素钠羧基转化为胺反应酯,然后在pH7.5的PBS缓冲溶液中,将双酚A单克隆抗体按照0.1μg/well 的量共价结合在羧甲基纤维素钠改性的活化位点上;用pH8.5的盐酸乙醇胺溶液除去未反应的NHS,再用PBST除去未连接的双酚A抗体。(5) The antibody was immobilized in the reaction zone: on the surface of the modified paper-based microfluidic chip, 3 μL EDC (4 mg/ml) and 3 μL NHS (6 mg/ml) were used for activation for 10 min. The carboxyl group was converted into an amine-reactive ester, and then the bisphenol A monoclonal antibody was covalently bound to the activated site modified by sodium carboxymethyl cellulose according to the amount of 0.1 μg/well in PBS buffer solution with pH 7.5; Unreacted NHS was removed with ethanolamine hydrochloride solution at pH 8.5, and unlinked bisphenol A antibody was removed with PBST.
(6)封闭:取1mg/mL的脱脂乳粉封闭液8μL,滴在纸基微流控孔中进行封闭,之后用PBST洗涤三次,洗涤过量的封闭液。(6) Blocking: Take 8 μL of 1 mg/mL skim milk powder blocking solution, drop it into the paper-based microfluidic well for blocking, and then wash with PBST three times to wash the excess blocking solution.
实施例5Example 5
本发明所述的一种基于喷蜡技术制备纸基微流控芯片用于检测双酚A的步骤如下:The steps of preparing a paper-based microfluidic chip for detecting bisphenol A based on the wax spray technology of the present invention are as follows:
(1)用CAD绘图:采用12×6阵列,反应区直径为5mm,孔间距为8mm,为了抑制样品在纸间流动,使用Auto CAD在白色背景上设计疏水屏障为黑色。(1) Drawing with CAD: A 12×6 array was used, the diameter of the reaction zone was 5 mm, and the hole spacing was 8 mm. In order to suppress the flow of the sample between the papers, Auto CAD was used to design the hydrophobic barrier to be black on a white background.
(2)蜡打印机打印:使用蜡打印机在滤纸上印刷微流控图案。(2) Wax printer printing: Microfluidic patterns were printed on filter paper using a wax printer.
(3)将打印好图案的色谱纸置于110℃烘箱中烘烤8min,将蜡融化。(3) Place the printed chromatographic paper in a 110°C oven for 8 minutes to melt the wax.
(4)纸基反应区表面改性:用羧甲基纤维素钠进行表面改性,具体步骤如下:将羧甲基纤维素钠溶解在去离子水中,用12kDa滤膜将其透析至无盐状态,在经冷冻干燥10min,将纯化后的羧甲基纤维素溶于氯化钙溶液中,取0.2g/L羧甲基纤维素钠15μL滴在制作好的纸基微流控孔中。(4) Surface modification of paper-based reaction zone: surface modification with sodium carboxymethyl cellulose, the specific steps are as follows: dissolving sodium carboxymethyl cellulose in deionized water, and dialyzing it with a 12kDa filter until it is salt-free After freeze-drying for 10 min, the purified carboxymethyl cellulose was dissolved in calcium chloride solution, and 15 μL of 0.2 g/L sodium carboxymethyl cellulose was dropped into the prepared paper-based microfluidic well.
(5)抗体固定于反应区中:在改性好的纸基微流控芯片表面上用6μL EDC(4 mg/mL)、6μL NHS(6mg/mL)活化18min,将羧甲基纤维素钠羧基转化为胺反应酯,然后在pH7.5的PBS缓冲溶液中,将双酚A单克隆抗体按照0.1μg/well 的量共价结合在羧甲基纤维素钠改性的活化位点上;用pH8.5的盐酸乙醇胺溶液除去未反应的NHS,再用PBST除去未连接的双酚A抗体。(5) The antibody was immobilized in the reaction zone: activated on the surface of the modified paper-based microfluidic chip with 6 μL EDC (4 mg/mL) and 6 μL NHS (6 mg/mL) for 18 min, and sodium carboxymethyl cellulose was activated for 18 min. The carboxyl group was converted into an amine-reactive ester, and then the bisphenol A monoclonal antibody was covalently bound to the activated site modified by sodium carboxymethyl cellulose according to the amount of 0.1 μg/well in PBS buffer solution with pH 7.5; Unreacted NHS was removed with ethanolamine hydrochloride solution at pH 8.5, and unlinked bisphenol A antibody was removed with PBST.
实施例6标准曲线绘制Example 6 standard curve drawing
(1)反应:将不同浓度的双酚A标品和酶标抗原以1:1的体积比加入到实施例 2得到的微流控反应孔中进行反应,之后用PBST缓冲溶液洗涤四次。分别取 1000μg/L、100μg/L、33.33μg/L、11.11μg/L、3.703μg/L、1.234μg/L、0.411μg/L、 0.137μg/L、0.045μg/L浓度的双酚A标品与酶标抗原以体积比1:1混合加入到芯片中进行反应。(1) Reaction: Different concentrations of bisphenol A standard substance and enzyme-labeled antigen were added to the microfluidic reaction well obtained in Example 2 at a volume ratio of 1:1 for reaction, and then washed four times with PBST buffer solution. Take 1000μg/L, 100μg/L, 33.33μg/L, 11.11μg/L, 3.703μg/L, 1.234μg/L, 0.411μg/L, 0.137μg/L, 0.045μg/L concentration of bisphenol A standard respectively. The product and the enzyme-labeled antigen were mixed at a volume ratio of 1:1 and added to the chip for reaction.
(2)显色:底物A和底物B混合,取5μL混合液加到微流控反应孔中进行显色,显色后及时用手机拍照。(2) Color development: Mix substrate A and substrate B, add 5 μL of the mixture to the microfluidic reaction well for color development, and take photos with a mobile phone in time after color development.
(3)分析:用Excel和Image J软件进行数据处理和灰度分析,绘制标准曲线。(3) Analysis: Data processing and grayscale analysis were performed with Excel and Image J software, and a standard curve was drawn.
显然不同浓度的标品对应的颜色也不同,由图4可见,标品浓度与灰度值呈正相关。依据此方法,可以建立相对灰度值与双酚A浓度一一对应的标准库,从而可以检测未知双酚A样品的浓度。Obviously, the corresponding colors of the standard products with different concentrations are also different. It can be seen from Figure 4 that the concentration of the standard products is positively correlated with the gray value. According to this method, a standard library with one-to-one correspondence between relative gray values and bisphenol A concentration can be established, so that the concentration of unknown bisphenol A samples can be detected.
所述的羧甲基纤维素钠分子量为250kDa。The molecular weight of the sodium carboxymethyl cellulose is 250kDa.
所述的盐酸乙醇胺溶液浓度为1M。The concentration of the ethanolamine hydrochloride solution is 1M.
实施例7质控品的检测The detection of
表1质控品双酚A含量检测精密度测试Table 1. Precision test for the detection of bisphenol A content in quality control products
由表1中检测数据可看出,批内变异系数(CV)最低值和最高值均控制在10%以内,表明该纸基芯片的精密度较好。It can be seen from the test data in Table 1 that the lowest and highest values of the intra-assay coefficient of variation (CV) are both controlled within 10%, indicating that the precision of the paper-based chip is good.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010288788.6A CN111521775A (en) | 2020-04-14 | 2020-04-14 | A method for preparing paper-based microfluidic chip for bisphenol A detection based on wax spray printing technology |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010288788.6A CN111521775A (en) | 2020-04-14 | 2020-04-14 | A method for preparing paper-based microfluidic chip for bisphenol A detection based on wax spray printing technology |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111521775A true CN111521775A (en) | 2020-08-11 |
Family
ID=71902639
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010288788.6A Pending CN111521775A (en) | 2020-04-14 | 2020-04-14 | A method for preparing paper-based microfluidic chip for bisphenol A detection based on wax spray printing technology |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111521775A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113237875A (en) * | 2021-04-27 | 2021-08-10 | 安徽省产品质量监督检验研究院(国家排灌及节水设备产品质量监督检验中心) | Detection method for rapidly detecting beta-stimulant and paper-based immunosensor |
CN113680406A (en) * | 2021-08-26 | 2021-11-23 | 清华大学 | Multi-index detection method for micro-fluidic chip |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103018467A (en) * | 2012-09-27 | 2013-04-03 | 江苏维赛科技生物发展有限公司 | Colloidal gold immunochromatographic card for detecting bisphenol A (BPA) and preparation method thereof |
CN103048445A (en) * | 2012-12-14 | 2013-04-17 | 广东工业大学 | Preparation method of bisphenol A-coated antigen with polylysine as carrier and application thereof |
US20140193840A1 (en) * | 2013-01-08 | 2014-07-10 | National Tsing Hua University | Chromatography filter paper-based elisa |
CN106622416A (en) * | 2017-03-13 | 2017-05-10 | 航天神舟生物科技集团有限公司 | Microfluidic paper chip for detection on human hypersensitive C-reactive protein, preparation method thereof and kit |
CN109061194A (en) * | 2018-09-12 | 2018-12-21 | 南京工业大学 | Paper-based device for rapidly detecting immune globulin and preparation method and application thereof |
TWI650557B (en) * | 2018-04-27 | 2019-02-11 | 國立臺灣大學 | Paper DC detection platform and using method thereof |
-
2020
- 2020-04-14 CN CN202010288788.6A patent/CN111521775A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103018467A (en) * | 2012-09-27 | 2013-04-03 | 江苏维赛科技生物发展有限公司 | Colloidal gold immunochromatographic card for detecting bisphenol A (BPA) and preparation method thereof |
CN103048445A (en) * | 2012-12-14 | 2013-04-17 | 广东工业大学 | Preparation method of bisphenol A-coated antigen with polylysine as carrier and application thereof |
US20140193840A1 (en) * | 2013-01-08 | 2014-07-10 | National Tsing Hua University | Chromatography filter paper-based elisa |
CN106622416A (en) * | 2017-03-13 | 2017-05-10 | 航天神舟生物科技集团有限公司 | Microfluidic paper chip for detection on human hypersensitive C-reactive protein, preparation method thereof and kit |
TWI650557B (en) * | 2018-04-27 | 2019-02-11 | 國立臺灣大學 | Paper DC detection platform and using method thereof |
CN109061194A (en) * | 2018-09-12 | 2018-12-21 | 南京工业大学 | Paper-based device for rapidly detecting immune globulin and preparation method and application thereof |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113237875A (en) * | 2021-04-27 | 2021-08-10 | 安徽省产品质量监督检验研究院(国家排灌及节水设备产品质量监督检验中心) | Detection method for rapidly detecting beta-stimulant and paper-based immunosensor |
CN113680406A (en) * | 2021-08-26 | 2021-11-23 | 清华大学 | Multi-index detection method for micro-fluidic chip |
CN113680406B (en) * | 2021-08-26 | 2022-04-15 | 清华大学 | Multi-index detection method for micro-fluidic chip |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Raz et al. | Multiplex bioanalytical methods for food and environmental monitoring | |
US9486770B2 (en) | Combinatoric encoding methods for microarrays | |
Seidel et al. | Automated analytical microarrays: a critical review | |
Wang et al. | based chemiluminescence ELISA: lab-on-paper based on chitosan modified paper device and wax-screen-printing | |
Tarannum et al. | Molecularly imprinted polymers as receptors for assays of antibiotics | |
Van Emon et al. | Bioseparation and bioanalytical techniques in environmental monitoring | |
Uludag et al. | Lab-on-a-chip based biosensor for the real-time detection of aflatoxin | |
Zubtsov et al. | Comparison of surface and hydrogel-based protein microchips | |
CN107121402A (en) | Chloramphenicol detection method in a kind of water body based on metal organic framework compound mimetic enzyme catalysis characteristic | |
CN111381038B (en) | A method for the simultaneous and rapid quantitative detection of tetracycline and chloramphenicol based on paper chip colorimetry | |
Hong et al. | A universal, portable, and ultra-sensitive pipet immunoassay platform for deoxynivalenol detection based on dopamine self-polymerization-mediated bioconjugation and signal amplification | |
CN105866105A (en) | Preparation and analysis method for chemiluminiscence imaging immunosensor for detecting multiple chicken cytokines | |
Sanchis et al. | Multiplexed immunochemical techniques for the detection of pollutants in aquatic environments | |
US20180120310A1 (en) | Method of and System for Printing In-Well Calibration Features | |
CN117849335A (en) | Label-free type multielement chemiluminescence imaging immune array sensor based on trimetallic CoCuFe-MOF nano enzyme | |
Belleville et al. | Quantitative microarray pesticide analysis | |
CN111521775A (en) | A method for preparing paper-based microfluidic chip for bisphenol A detection based on wax spray printing technology | |
Liu et al. | Flow-through immunosensors using antibody-immobilized polymer monoliths | |
Ahmed et al. | Specific capture of target proteins by oriented antibodies bound to tyrosinase-immobilized Protein A on a polyallylamine affinity membrane surface | |
WO2008018566A1 (en) | Colloidal silica particle containing light-absorbing substance, nano light-absorbing material, absorption labeling nanobead kit, and method for detection or quantification of biological molecule using the colloidal silica particle containing light-absorbing substance | |
CN111879920A (en) | Multi-component unmarked immunosensor based on single metal Cu-MOF mimic enzyme | |
Jang et al. | In situ electrochemical enzyme immunoassay on a microchip with surface-functionalized poly (dimethylsiloxane) channel | |
CN106353500A (en) | Multi-tumor marker label-free chemiluminescent imaging immunosensor preparation and analysis method | |
US7846713B2 (en) | Calibrating microarrays | |
Marquette et al. | Protein microarrays enhanced performance using nanobeads arraying and polymer coating |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200811 |
|
RJ01 | Rejection of invention patent application after publication |